Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 97,100 shares at $58.09 ($5.7M) on 2020-05-15, disclosed to the SEC on 2020-05-19.
Open-market sale of $5.7M KRYS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.43 | 3,842 | $221K | 3.9% |
| 2 | $57.43 | 3,842 | $221K | 3.9% |
| 3 | $58.09 | 12,445 | $723K | 12.8% |
| 4 | $58.09 | 12,445 | $723K | 12.8% |
| 5 | $59.03 | 10,552 | $623K | 11.0% |
| 6 | $59.03 | 10,552 |
| $623K |
| 11.0% |
| 7 | $55.99 | 2,900 | $162K | 2.9% |
| 8 | $56.84 | 6,784 | $386K | 6.8% |
| 9 | $56.84 | 6,784 | $386K | 6.8% |
| 10 | $57.63 | 5,371 | $310K | 5.5% |
| 11 | $57.63 | 5,371 | $310K | 5.5% |
| 12 | $59.11 | 1,805 | $107K | 1.9% |
| 13 | $59.11 | 1,805 | $107K | 1.9% |
| 14 | $59.73 | 6,301 | $376K | 6.7% |
| 15 | $59.73 | 6,301 | $376K | 6.7% |
| Total | $58.20 avg | 97,100 | $5.7M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |